These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 3245494)

  • 21. A brief review of the biochemistry and pharmacology of Eglin c, an elastase inhibitor.
    Braun NJ; Schnebli HP
    Eur J Respir Dis Suppl; 1986; 146():541-7. PubMed ID: 3536558
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Kinetics of the inhibition of human pancreatic elastase by recombinant eglin c. Influence of elastin.
    Faller B; Dirrig S; Rabaud M; Bieth JG
    Biochem J; 1990 Sep; 270(3):639-44. PubMed ID: 1700695
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protein and amino acid metabolism in posterior hemicorpus of acutely uremic rats.
    Flügel-Link RM; Salusky IB; Jones MR; Kopple JD
    Am J Physiol; 1983 Jun; 244(6):E615-23. PubMed ID: 6305204
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of horse leucocyte proteinases by eglin, a proteinase inhibitor from leeches.
    Potempa J; Dubin A; Seemüller U; Schnebli HP; Koj A
    Biomed Biochim Acta; 1985; 44(2):335-9. PubMed ID: 4004837
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of the elastase inhibitor eglin C in porcine endotoxin shock.
    Siebeck M; Hoffmann H; Weipert J; Fritz H
    Circ Shock; 1992 Mar; 36(3):174-9. PubMed ID: 1351797
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition by elastase inhibitors of the formyl Met Leu Phe-induced chemotaxis of rat polymorphonuclear leukocytes.
    Hornebeck W; Soleilhac JM; Tixier JM; Moczar E; Robert L
    Cell Biochem Funct; 1987 Apr; 5(2):113-22. PubMed ID: 3495371
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structure of the proteinase inhibitor eglin c with hydrolysed reactive centre at 2.0 A resolution.
    Betzel C; Dauter Z; Genov N; Lamzin V; Navaza J; Schnebli HP; Visanji M; Wilson KS
    FEBS Lett; 1993 Feb; 317(3):185-8. PubMed ID: 8425603
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Elastase-cathepsin G inhibitors eglin b and eglin c differ by a single Tyr----His substitution. A micro-method for the identification of amino-acid substitution.
    Chang JY; Knecht R; Maschler R; Seemüller U
    Biol Chem Hoppe Seyler; 1985 Mar; 366(3):281-6. PubMed ID: 4005044
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Free radicals inactivate human neutrophil elastase and its inhibitors with comparable efficiency.
    Dean RT; Nick HP; Schnebli HP
    Biochem Biophys Res Commun; 1989 Mar; 159(2):821-7. PubMed ID: 2784675
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of varying the time interval between intratracheal administration of eglin-c and human neutrophil elastase on prevention of emphysema and secretory cell metaplasia in hamsters. With observations on the fate of eglin-c and the effect of repeated instillations.
    Lucey EC; Stone PJ; Christensen TG; Breuer R; Calore JD; Snider GL
    Am Rev Respir Dis; 1986 Sep; 134(3):471-5. PubMed ID: 3530070
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of some natural and semisynthetic agents on elastase and cathepsin G from polymorphonuclear granulocytes.
    Steinmeyer J; Kalbhen DA
    Arzneimittelforschung; 1991 Jan; 41(1):77-80. PubMed ID: 1710897
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Control of exogenous proteinases and their inhibitors at the macrophage cell surface.
    Dean RT; Schnebli HP
    Biochim Biophys Acta; 1989 Aug; 992(2):174-80. PubMed ID: 2758063
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic effects of the combination of two proteinase inhibitors in endotoxin shock of the pig.
    Siebeck M; Hoffmann H; Weipert J; Spannagl M
    Prog Clin Biol Res; 1989; 308():937-43. PubMed ID: 2780741
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biochemical properties and possible therapeutic role of the elastase inhibitor eglin C.
    Schnebli HP; Seemüller U; Fritz H; Maschler R; Liersch M; Bodmer JL; Virca GD; Lucey EC; Stone PG; Snider GL
    Prog Clin Biol Res; 1985; 180():287-90. PubMed ID: 3849804
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of the elastase inhibitor, eglin-c, on antibacterial mechanisms in experimental pneumonia. Description of a system to quantitate phagocytic and bactericidal activity of resident murine alveolar macrophages in vivo.
    Esposito AL; Quinn LA; Lucey EC; Snider GL
    Am Rev Respir Dis; 1987 Mar; 135(3):676-81. PubMed ID: 3644606
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Binding of the recombinant proteinase inhibitor eglin c from leech Hirudo medicinalis to serine (pro)enzymes: a comparative thermodynamic study.
    Ascenzi P; Aducci P; Amiconi G; Ballio A; Guaragna A; Menegatti E; Schnebli HP; Bolognesi M
    J Mol Recognit; 1991; 4(4):113-9. PubMed ID: 1799460
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis of peptide fragments related to eglin c and examination of their inhibitory effect on human leukocyte elastase, cathepsin G and alpha-chymotrypsin.
    Okada Y; Tsuboi S; Tsuda Y; Nakabayashi K; Nagamatsu Y; Yamamoto J
    Biochem Biophys Res Commun; 1989 May; 161(1):272-5. PubMed ID: 2730658
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Calpain is activated in experimental uremia: is calpain a mediator of uremia-induced myocardial injury?
    Harwood SM; Allen DA; Chesser AM; New DI; Raftery MJ; Yaqoob MM
    Kidney Int; 2003 Mar; 63(3):866-77. PubMed ID: 12631067
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis of a trihexacontapeptide corresponding to the sequence 8-70 of eglin c and studies on the relationship between the structure and the inhibitory activity against human leukocyte elastase, cathepsin G and alpha-chymotrypsin.
    Okada Y; Tsuboi S; Tsuda Y; Nagamatsu Y; Yamamoto J
    FEBS Lett; 1990 Oct; 272(1-2):113-6. PubMed ID: 2226822
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of exercise training on muscle protein catabolism in uremia.
    Davis TA; Karl IE; Goldberg AP; Harter HR
    Kidney Int Suppl; 1983 Dec; 16():S52-7. PubMed ID: 6376921
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.